1-(2-methoxyphenyl)-4-alkylpiperazines: Effect of the N-4 substitutent on the affinity and selectivity for dopamine D4 receptor

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 10, 1997, Pages 1327-1330

  Perrone, Roberto ^a   Berardi, Francesco ^a   Colabufo, Nicola A ^a   Leopoldo, Marcello ^a   Tortorella, Vincenzo ^a  

^a Dipartimento Farmaco Chimico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; RECEPTOR SUBTYPE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GENE EXPRESSION; HUMAN; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0031579944     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00218-7     Document Type: Article

References (18)

1. Sokoloff P., Giros B., Martres M.-P., Bouthenet M.-L., Schwartz J.-C. Nature. 347:1990;146-151.
2. Van Tol H.H.M., Bunzow J.R., Guan H.-C., Sunahara R.K., Seeman P., Niznik H.B. Civelli. O. Nature. 350:1991;610-614.
3. Bouthenet M.-L., Souil E., Martres M.-P., Sokoloff P., Giros B., Schwartz J.-C. Brain Res. 564:1991;203-219.
4. Seeman P. Neuropsychopharmacology. 7:1992;261-284.
5. Seeman P., Guan H.-C., Van Tol H.H.M. Nature. 365:1993;441-445.
6. Hadley M.S. Med. Res. Rev. 16:1996;507-526.
7. Thurkauf A., Yuan J., Chen X., Wasley J.W.F., Meade R., Harris Woodruff K., Huston K., Ross P.C. J. Med. Chem. 38:1995;4950-4952.
8. Thurkauf A., Yuan J., Chen X., Wasley J.W.F., Paneitz G., Meade R., Harris Woodruff K., Huston K., Ross P.C. Med. Chem. Res. 6:1996;69-80.
9. Perrone R., Berardi F., Colabufo N.A., Tortorella V., Fiorentini F., Olgiati V., Vanotti E., Govoni S. J. Med. Chem. 37:1994;99-104.
10. Perrone R., Berardi F., Colabufo N.A., Leopoldo M., Tortorella V., Fiorentini F., Olgiati V., Ghiglieri A., Govoni S. J. Med. Chem. 38:1995;942-949.
11. Perrone R., Berardi F., Leopoldo M., Tortorella V., Fornaretto M.G., Caccia C., McArthur R. J. Med. Chem. 39:1996;3195-3202.
12. Perrone R., Berardi F., Colabufo N.A., Leopoldo M., Tortorella V., Fornaretto M.G., Caccia C., McArthur R. J. Med. Chem. 39:1996;4928-4937.
13. Perrone R., Berardi F., Leopoldo M., Tortorella V., Lograno M.D., Daniele E., Govoni S. Farmaco. 50:1995;505-510.
14. Hunig, S.; Wehner, G. Synthesis, 1975, 180-182.
15. All new compounds exhibited satisfactory spectral and elemental analysis data.
16. 2) and 100 μL of various concentration of drugs in 1 mL of total volume. The tubes were incubated at 25 °C for 60 minutes and filtered over Whatman GF/C presoaked in P.E.I. 0.3%, then washed two times with 1 mL of ice cold buffer (50 mM Tris·HCl, pH 7.4). Nonspecific binding was determinated in presence of haloperidol 1 μM. Clozapine was used as reference compound.
17. d = 0.2 nM), 450 μL of diluted rat striatum membranes, 300 mL of various concentration of drugs in 3 mL of total volume. Nonspecific binding was determinated in the presence of haloperidol 1 μM.
18. Glossman H., Hornung R. Eur. J. Pharmacol. 61:1980;407-408.